Board and Executive Management

Board

Jörg-Michael Rupp, Roche (President)

Katrien De Vos, AstraZeneca (Vicepresident)

Stefan Hendriks, Novartis (Vicepresident)

Leila Schwery-Bou-Diab, Johnson & Johnson (Vicepresident)

Sabine Bruckner, Pfizer

René P. Buholzer, Interpharma (Delegierter des Vorstands)

Graham Dorey, Biogen

Thorsten Hein, Bayer

Colleen Kamrad, GSK

Matthias Leuenberger, Novartis

Michael Lugez, BMS

Andrea Michael Meyer, Sanofi

Pierre Morneau, Takeda

Max Pahlow, Johnson & Johnson

Dan Staner, Moderna

Nathalie Stieger, F. Hoffmann-La Roche

Mads Stoustrup, Novo Nordisk

Executive management

Dr. René P. Buholzer

Managing director

Susanne Müller

Member of the Executive Board / Services

Markus A. Ziegler

Member of the Executive Board / Head of Markets

Yves Weidmann

Member of the Executive Board / Head of Governmental Affairs

Samuel Lanz

Member of the Executive Board / Head of Communications

+41 61 264 34 85

Dr. Tanja Colin

Member of the Executive Board / Head of Approval & Technology

Simon Fry

Member of the Executive Board / Head of Innovation & IPR

Media contacts

Michèle Sierro

Communication Manager Romandie

+41 79 305 84 30

Samuel Lanz

Member of the Executive Board / Head of Communications

+41 61 264 34 85

Board and Executive Management

Introducing Interpharma

Annual report

Information on our key figures and activities in the financial year 2022

Contact

Vision and Mission

More about the tasks and overriding aims of Interpharma

Publications

Order and download publications.